China National Accord Medicines (SZSE:200028) Other Long-Term Liabilities : HK$806 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Other Long-Term Liabilities?

China National Accord Medicines's other long-term liabilities for the quarter that ended in Mar. 2024 was HK$806 Mil.

China National Accord Medicines's quarterly other long-term liabilities declined from Sep. 2023 (HK$888 Mil) to Dec. 2023 (HK$879 Mil) and declined from Dec. 2023 (HK$879 Mil) to Mar. 2024 (HK$806 Mil).

China National Accord Medicines's annual other long-term liabilities declined from Dec. 2021 (HK$1,145 Mil) to Dec. 2022 (HK$892 Mil) and declined from Dec. 2022 (HK$892 Mil) to Dec. 2023 (HK$879 Mil).

China National Accord Medicines Other Long-Term Liabilities Historical Data

The historical data trend for China National Accord Medicines's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Other Long-Term Liabilities Chart

China National Accord Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

China National Accord Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

China National Accord Medicines Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

China National Accord Medicines Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:200028) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:200028) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

000028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:200028) Headlines

No Headlines